DaVita HealthCare Partners (DVA): An Intelligent Fanatic Led Turn Around
From 1999-2016, Thiry turned DaVita from a $200 million microcap on the brink of failure into a $16 Billion midcap and the best dialysis company in the world.
From 1999-2016, Thiry turned DaVita from a $200 million microcap on the brink of failure into a $16 Billion midcap and the best dialysis company in the world.
On February 1, 2009, Todd M. Cleveland became the CEO of a $5 million market cap microcap called Patrick Industries (PATK). In just seven years, he would transform the company through acquisitions and organic growth into a $61 per share, $940 million market cap, compounding machine.
DGHM & Co recently published a white paper, Microcaps: Value Uncovered. In the white paper, they illustrate that Microcaps have outperformed Large Caps since 1926.
Over the next 15 years, Selim Bassoul would transform Middleby Corporation from an unfocused, cultureless, slow moving, sleepy food equipment manufacturer into a compounding machine.
For his amazing track record, very few investors have heard of Astman. He spent his entire investment career under the radar.
Incredibly, $1 invested in MTY stock in 2003 would go on to be worth $100 by 2013.